Trial Profile
Efficacy and safety of dextromethorphan/quinidine in prophylactic treatment of migraine in patients with multiple sclerosis with superimposed pseudobulbar affect
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Dextromethorphan/quinidine (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- 27 Feb 2018 New trial record
- 22 Feb 2018 Results published in the Clinical Neuropharmacology